WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Janux Therapeutics earnings were -$101.9M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest JANX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$24.3M, down 28.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JANX reported annual earnings of -$69.0M, with 18.4% growth.

JANX earnings history

Current Revenue
$10.0M
Current Earnings
-$101.9M
Current Profit Margin
-1,019%

JANX Return on Equity

Current Company
-10.2%
Current Industry
-21.3%
Current Market
35.2%
JANX's Return on Equity (-10.2%)... subscribe to Premium to read more.
High Return on Equity Performance

JANX undefined

Current Company
-9.8%
Current Industry
-8.8%
JANX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when JANX announces earnings.

JANX undefined

Current Company
-10.22%
Current Industry
-3.4%
JANX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JANX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
JANX-$99.82M-$101.90MN/A-$1.67
MRVI-$33.50M-$121.24MN/A-$0.84
TBPH$55.37M$29.34M-98.26%$0.58
CMPX-$64.35M-$65.81MN/A-$0.45
ORIC-$134.07M-$135.27MN/A-$1.73
View Top Biotech Stocks

Janux Therapeutics Earnings Reports & History FAQ

What were Janux Therapeutics's earnings last quarter?

On JANX's earnings call on Invalid Date, Janux Therapeutics (NASDAQ: JANX) reported Q3 2025 earnings per share (EPS) of -$0.39, up 23.53% year over year. Total JANX earnings for the quarter were -$24.31 million. In the same quarter last year, Janux Therapeutics's earnings per share (EPS) was -$0.51.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.

Is Janux Therapeutics profitable or losing money?

As of the last Janux Therapeutics earnings report, Janux Therapeutics is currently losing money. Janux Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$101.90 million, a 68.32% increase year over year.

What was JANX's earnings growth in the past year?

As of Janux Therapeutics's earnings date in Invalid Date, Janux Therapeutics's earnings has grown year over year. JANX earnings in the past year totalled -$101.90 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.